From a therapeutic benefit standpoint, impaired GLP-1 secretion mediated by blood glucose has been observed in MASLD patients
How Protein Triggers Your Bodys Natural GLP-1 Response When you eat protein-rich foods, something amazing happens in your digestive system
Mortality and serious adverse events associated with glucagon-like peptide-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system
Lead author and pharmacist, Associate Professor Luke Grzeskowiak, says that in 2022 alone, more than 6,000 women began treatment on GLP-1s, and over 90% of those did not have a diabetes diagnosis
Curcumin and curcuminoids in quest for medicinal status
Note on Off-Label Use and Our Standard of Care You will recall we discussed that some brand names of semaglutide, like Ozempic, are FDA-approved for type 2 diabetes, but are often prescribed for weight managementa practice known as off-label use